✦ LIBER ✦

HIGH-THROUGHPUT CRYSTALLOGRAPHY FOR LEAD DISCOVERY IN DRUG DESIGN

✍ Scribed by Blundell, Tom L.; Jhoti, Harren; Abell, Chris

Book ID: 109951395
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 491 KB
Volume: 1
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd706

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Throughput Protein Crystallography

High-Throughput Protein Crystallography and Drug Discovery

✍ Ian Tickle; Andrew Sharff; Mladen Vinkovic; Jeff Yon; Harren Jhoti 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

High-throughput crystallography to enhan

High-throughput crystallography to enhance drug discovery

✍ Andrew Sharff; Harren Jhoti 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Protein crystallography has traditionally been regarded as a resource-intensive, time-consuming technique that, with some notable exceptions, has not made a significant impact on drug discovery. However, inspired by successes in the genome-sequencing initiatives, recent years have seen major changes

Lead Generation Approaches in Drug Disco

Lead Generation Approaches in Drug Discovery (Rankovic/Lead Generation) || High Throughput Screening Approach to Lead Discovery

✍ Rankovic, Zoran; Morphy, Richard 📂 Article 📅 2010 🏛 John Wiley & Sons, Inc. ⚖ 1012 KB

High throughput physicochemical profilin

High throughput physicochemical profiling for drug discovery

✍ Edward H. Kerns 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

Cytotoxicity tests for high-throughput d

Cytotoxicity tests for high-throughput drug discovery

✍ Kevin Slater 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Despite theoretical obstacles associated with performing cell-based assays in high-density formats (microplates with at least 384 wells), it is becoming clear that the pharmaceutical industry is now routinely running cell-based tests in these formats. This work is revealing the weakness of establish

The genesis of high-throughput structure

The genesis of high-throughput structure-based drug discovery using protein crystallography

✍ Peter Kuhn; Keith Wilson; Marianne G Patch; Raymond C Stevens 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Over the past 12 years, drugs have been developed using structure-based drug design relying upon traditional crystallographic methods. Established successes, such as the drugs designed against HIV-1 protease and neuraminidase, demonstrate the utility of a structure-based approach in the drug-discove